Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: An underappreciated entity

Otology and Neurotology

Volumn 33, Issue 3, 2012, Pages 473-480

  Roosli, Christof ^a,b   Linthicum, Fred H ^c   Cureoglu, Sebahattin ^d   Merchant, Saumil N ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HOUSE EAR INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cochlear changes; Estibular schwannoma; Hair cell loss; Hearing loss; Temporal bone histopathology

Indexed keywords

ADULT; AGED; ARTICLE; BONE CONDUCTION; CLINICAL TRIAL; COCHLEA; FEMALE; HAIR CELL; HEARING LOSS; HUMAN; INNER EAR DISEASE; INNERVATION; MALE; MIDDLE AGED; MULTICENTER STUDY; NERVE CELL; NEUROMA; PATHOLOGY; PHYSIOLOGY; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; SPEECH AUDIOMETRY; TEMPORAL BONE; VESTIBULAR NERVE;

ADULT; AGED; AGED, 80 AND OVER; AUDIOMETRY, PURE-TONE; BONE CONDUCTION; COCHLEA; COCHLEAR DISEASES; FEMALE; HAIR CELLS, AUDITORY, INNER; HAIR CELLS, AUDITORY, OUTER; HEARING LOSS; HUMANS; MALE; MIDDLE AGED; NEUROMA, ACOUSTIC; NEURONS; RETROSPECTIVE STUDIES; SPEECH DISCRIMINATION TESTS; TEMPORAL BONE; VESTIBULAR NERVE;

EID: 84861102183     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318248ee02     Document Type: Article

References (52)

1. Harner SG, Fabry DA, Beatty CW. Audiometric findings in patients with acoustic neuroma. Am J Otol 2000;21:405-11. (Pubitemid 30305040)
2. Saliba I, Martineau G, Chagnon M. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma. Otol Neurotol 2009; 30:515-21.
3. Gimsing S. Vestibular schwannoma: when to look for it? J Laryngol Otol 2010;124:258-64.
4. Selters WA, Brackmann DE. Acoustic tumor detection with brainstem electric response audiometry. Arch Otolaryngol 1977;103: 181-7.
5. Bozorg Grayeli A, Refass A, Smail M, et al. Diagnostic value of auditory brainstem responses in cerebellopontine angle tumours. Acta Otolaryngol 2008;128:1096-100.
6. Eckermeier L, Pirsig W, Mueller D. Histopathology of 30 nonoperated acoustic schwannomas. Arch Otorhinolaryngol 1979;222: 1-9.
7. Johnsson LG, Hawkins JE Jr, Rouse RC. Sensorineural and vascular changes in an ear with acoustic neurinoma. Am J Otolaryngol 1984;5:49-59. (Pubitemid 14009076)
8. Bonfils P, Uziel A. Evoked otoacoustic emissions in patients with acoustic neuromas. Am J Otol 1988;9:412-7. (Pubitemid 19013460)
9. Prasher DK, Tun T, Brookes GB, et al. Mechanisms of hearing loss in acoustic neuroma: an otoacoustic emission study. Acta Otolaryngol 1995;115:375-81.
10. Telischi F. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas. Laryngoscope 2000;110:553-62. (Pubitemid 30198707)
11. Gouveris HT, Victor A, Mann WJ. Cochlear origin of early hearing loss in vestibular schwannoma. Laryngoscope 2007;117:680-3. (Pubitemid 46559047)
12. Dix MR, Hallpike CS. Observations on the pathological mechanism of conductive deafness in certain cases of neuroma of the VIII nerve. Proc R Soc Med 1950;43:291-8.
13. Perez de Moura LF. Inner ear pathology in acoustic neuroma. Arch Otolaryngol 1967;85:125-33.
14. Schuknecht HF, McNeill RA. Light microscopic observations on the pathology of endolymph. J Laryngol Otol 1966;80:1-10.
15. Suga F, Lindsay JR. Inner ear degeneration in acoustic neurinoma. Ann Otol Rhinol Laryngol 1976;85:343-58.
16. Nager GT. Acoustic schwannomas. In: Nager GT, Hyams VJ, eds. Pathology of the Ear and Temporal Bone. Baltimore, MD: Williams and Wilkins, 1993:515-67.
17. Mahmud MR, Kahn AM, Nadol JB Jr. Histopathology of the inner ear in unoperated acoustic neuroma. Ann Otol Rhinol Laryngol 2003;112:979-86. (Pubitemid 37429643)
18. Otte J, Schunknecht HF, Kerr AG. Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. Laryngoscope 1978;88:1231-46.
19. Pauler M, Schuknecht HF, Thornton AR. Correlative studies of cochlear neuronal loss with speech discrimination and pure-tone thresholds. Arch Otorhinolaryngol 1986;243:200-6. (Pubitemid 16074014)
20. Schuknecht HF. Auditory and cytocochlear correlates of inner ear disorders. Otolaryngol Head Neck Surg 1994;110:530-8. (Pubitemid 24204252)
21. Schuknecht HF, Woellner RC. An experimental and clinical study of deafness from lesions of the cochlear nerve. J Laryngol Otol 1955;69:75-97.
22. Jerger J. Audiological manifestations of lesions in the auditory nervous system. Laryngoscope 1960;70:417-25.
23. Nadol JB Jr, Levine R, Ojemann RG, et al. Preservation of hearing in surgical removal of acoustic neuromas of the internal auditory canal and cerebellar pontine angle. Laryngoscope 1987;97:1287-94. (Pubitemid 18030650)
24. Chee GH, Nedzelski JM, Rowed D. Acoustic neuroma surgery: the results of long-term hearing preservation. Otol Neurotol 2003; 24:672-6. (Pubitemid 36886288)
25. Gjuric M, Mitrecic MZ, Greess H, et al. Vestibular schwannoma volume as a predictor of hearing outcome after surgery. Otol Neurotol 2007;28:822-7. (Pubitemid 47329899)
26. Kim CH, Chung KW, Kong DS, et al. Prognostic factors of hearing preservation after gamma knife radiosurgery for vestibular schwannoma. J Clin Neurosci 2010;17:214-8.
27. Woodson EA, Dempewolf RD, Gubbels SP, et al. Long-term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol 2010;31:1144-52.
28. Arriaga MA, Long S, Nelson R. Clinical correlates of acoustic neuroma volume. Am J Otol 1993;14:465-8. (Pubitemid 23280383)
29. Nadol JB Jr, Diamond PF, Thornton AR. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic neuromas). Am J Otol 1996;17:312-6. (Pubitemid 26171776)
30. Merchant SN. Methods of removal, preparation and study. In Merchant SN, Nadol JB, eds. Schuknecht's pathology of the ear. Shelton, CT: PMPH, 2010:3-51.
31. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117:1175-83. (Pubitemid 46718402)
32. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NFkappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010;21:11-9.
33. Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 2002;23:316-22. (Pubitemid 34506640)
34. Silverstein H. Labyrinthine tap as a diagnostic test for acoustic neurinoma. Otolaryngol Clin North Am 1973;6:229-44.
35. Silverstein H. A rapid protein test for acoustic neurinoma. Arch Otolaryngol 1972;95:202-4.
36. Silverstein H. Schuknecht HF. Biochemical studies of inner ear fluid in man. Changes in otosclerosis, meniere's disease, and acoustic neuroma. Arch Otolaryngol 1966;84:395-402.
37. Lysaght AC, Kao SY, Paulo JA, et al. Proteome of human perilymph. J Proteome Res 2011;10:3845-51.
38. Telischi FF, Roth J, Stagner BB, et al. Patterns of evoked otoacoustic emissions associated with acoustic neuromas. Laryngoscope 1995;105:675-82.
39. Ferri GG, Modugno GC, Calbucci F, et al. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions. Auris Nasus Larynx 2009;36:644-8.
40. Murofushi T, Takehisa M. Vestibular schwannoma with absent vestibular evoked myogenic potentials to clicks but normal ABR, caloric responses and vestibular evoked myogenic potentials to 500 Hz tone bursts. Acta Otolaryngol 2010;130:525-8.
41. Chaimoff M, Nageris BI, Sulkes J, et al. Sudden hearing loss as a presenting symptom of acoustic neuroma. Am J Otolaryngol 1999; 20:157-60. (Pubitemid 29196561)
42. Nageris BI, Popovtzer A. Acoustic neuroma in patients with completely resolved sudden hearing loss. Ann Otol Rhinol Laryngol 2003;112:395-7. (Pubitemid 36617549)
43. Sauvaget E, Kici S, Kania R, et al. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Otolaryngol 2005;125:592-5. (Pubitemid 40874173)
44. Berenholz LP, Eriksen C, Hirsh FA. Recovery from repeated sudden hearing loss with corticosteroid use in the presence of an acoustic neuroma. Ann Otol Rhinol Laryngol 1992;101:827-31.
45. Aronzon A, Ruckenstein MJ, Bigelow DC. The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas. Otol Neurotol 2003;24:465-8. (Pubitemid 36618170)
46. Tringali S, Ferber-Viart C, Fuchsmann C, et al. Hearing preservation in retrosigmoid approach of small vestibular schwannomas: prognostic value of the degree of internal auditory canal filling. Otol Neurotol 2010;31:1469-72.
47. Rabelo de Freitas M, Russo A, Sequino G, et al. Analysis of hearing preservation and facial nerve function for patients undergoing vestibular schwannoma surgery: the middle cranial fossa approach versus the retrosigmoid approachVpersonal experience and literature review. Audiol Neurootol 2011;17:71-81.
48. Roos DE, Potter AE, Brophy BP. Stereotactic radiosurgery for acoustic neuromas: what happens long term? [Published online ahead of print June 21, 2011]. Int J Radiat Oncol Biol Phys.
49. Gadre AK, Kwartler JA, Brackmann DE, et al. Middle fossa decompression of the internal auditory canal in acoustic neuroma surgery: a therapeutic alternative. Laryngoscope 1990;100:948-52. (Pubitemid 20301593)
50. Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009;361:358-67.
51. Mautner VF, Nguyen R, Kutta H, et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 2010;12:14-8.
52. Blair KJ, Kiang A, Wang-Rodriguez J, et al. EGF and bFGF promote invasion that is modulated by PI3/Akt kinase and Erk in vestibular schwannoma. Otol Neurotol 2011;32:308-14.